Common reactions include nausea, constipation, diarrhea, and bloating
The women who were prescribed GLP-1 medications had a 35.1% lower risk of developing breast cancer
Jeremy Appleton, ND, Director of Medical and Scientific Affairs for PLT PLT, in association with Isocell S.A., announced the publication of the results of a new human clinical study using their exclusive dietary supplement ingredient, GliSODin in The International Journal of Sport Nutrition and Exercise Metabolism
doi: 10.1016/j.abb.2018.03.030 240 GreilRGreil-ResslerSWeissLSchnliebCMagnesTRadlBet al
David Oliak, MD, and PA Allison Mollet, PA-C, have worked together since 2006 first in Dr
A study to evaluate the effectiveness and safety of Dysport for the prevention of chronic migraine in adults